Insights

Key Personnel Expansion Recent hires of Chief Development Officer and Chief Business Officer indicate company growth and potential need for new solutions or services.

Strategic Partnerships Established worldwide collaboration with Sanofi for developing IL-10 receptor agonists presents partnership opportunities to provide complementary products or services.

Innovative Therapeutic Programs Launching unique therapies like CD19 CAR-T combination therapy and IL-12 partial agonist program opens avenues for collaborations or cross-selling opportunities in the biotechnology sector.

Financial Capacity Significant funding of $100M and revenue range of $10M - $50M showcase financial stability, suggesting capacity for investing in advanced solutions or products.

Market Positioning Being part of a competitive landscape dominated by companies with varied sizes and revenues, Synthekine may seek strategic solutions to differentiate and capture market share.

Synthekine Tech Stack

Synthekine uses 8 technology products and services including Google Analytics, Cloudflare CDN, Google Font API, and more. Explore Synthekine's tech stack below.

  • Google Analytics
    Analytics
  • Cloudflare CDN
    Content Delivery Network
  • Google Font API
    Font Scripts
  • Lightbox
    Javascript Libraries
  • RSS
    Miscellaneous
  • Open Graph
    Miscellaneous
  • PWA
    Miscellaneous
  • Kinsta
    Platform As A Service

Media & News

Synthekine's Email Address Formats

Synthekine uses at least 1 format(s):
Synthekine Email FormatsExamplePercentage
FLast@synthekine.comJDoe@synthekine.com
50%
FLast@synthekine.comJDoe@synthekine.com
50%

Frequently Asked Questions

Where is Synthekine's headquarters located?

Minus sign iconPlus sign icon
Synthekine's main headquarters is located at 1505 Obrien Drive Suite A/D Menlo Park, California 94025 US. The company has employees across 1 continents, including North America.

What is Synthekine's official website and social media links?

Minus sign iconPlus sign icon
Synthekine's official website is synthekine.com and has social profiles on LinkedIn.

How much revenue does Synthekine generate?

Minus sign iconPlus sign icon
As of November 2024, Synthekine's annual revenue reached $15M.

What is Synthekine's SIC code NAICS code?

Minus sign iconPlus sign icon
Synthekine's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Synthekine have currently?

Minus sign iconPlus sign icon
As of November 2024, Synthekine has approximately 102 employees across 1 continents, including North America. Key team members include Chief Executive Officer: D. R.Chief Technology Officer: G. Y.Chief Business Officer: G. N.. Explore Synthekine's employee directory with LeadIQ.

What industry does Synthekine belong to?

Minus sign iconPlus sign icon
Synthekine operates in the Biotechnology Research industry.

What technology does Synthekine use?

Minus sign iconPlus sign icon
Synthekine's tech stack includes Google AnalyticsCloudflare CDNGoogle Font APILightboxRSSOpen GraphPWAKinsta.

What is Synthekine's email format?

Minus sign iconPlus sign icon
Synthekine's email format typically follows the pattern of . Find more Synthekine email formats with LeadIQ.

How much funding has Synthekine raised to date?

Minus sign iconPlus sign icon
As of November 2024, Synthekine has raised $100M in funding. The last funding round occurred on Jan 06, 2023 for $100M.

When was Synthekine founded?

Minus sign iconPlus sign icon
Synthekine was founded in 2018.
Synthekine

Synthekine

Biotechnology ResearchCalifornia, United States51-200 Employees

Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders. Using the principles of cytokine partial agonism and immunological specificity, Synthekine designs differentiated therapeutics to be both safe and efficacious. Its lead programs have shown promising efficacy and tolerability in preclinical studies, and it is developing additional cytokine partial agonists that selectively modulate key pathways of the immune system.

Section iconCompany Overview

Headquarters
1505 Obrien Drive Suite A/D Menlo Park, California 94025 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $100M

    Synthekine has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on Jan 06, 2023 in the amount of $100M.

  • $10M$50M

    Synthekine's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $100M

    Synthekine has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on Jan 06, 2023 in the amount of $100M.

  • $10M$50M

    Synthekine's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.